AT-0174
Product Specifications
UNSPSC Description
AT-0174 is an orally active dual inhibitor of IDO1/TDO2 (tryptophan 2,3-dioxygenase-2) with IC50 values of 0.17 and 0.25 μM, respectively. AT-0174 has antitumor activity[1][2].
Target Antigen
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/at-0174.html
Solubility
10 mM in DMSO
Smiles
NC1NOC2=NC(Cl)=C(F)C=C21
Molecular Weight
189.57
References & Citations
[1]Crump LS, et al. Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression. Cancer Res Commun. 2024 Mar 7.|[2]Crump LS, et al. Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression. Cancer Res Commun. 2024 Mar 7.|[3]Wu C, et al. Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer. Cancer Metab. 2023 May 24;11(1):7.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
48054111 3x 1.0 µg
TRNAG29 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
MBS6371113-01 0.1 mL
BCL2L10 (Bcl-2-like Protein 10, Bcl2-L-10, Anti-apoptotic Protein NrH, Apoptosis Regulator Bcl-B, BCLB) APC
Sign In for Pricing
View Details MBS6371113-02 5x 0.1 mL
BCL2L10 (Bcl-2-like Protein 10, Bcl2-L-10, Anti-apoptotic Protein NrH, Apoptosis Regulator Bcl-B, BCLB) APC
Sign In for Pricing
View Details 
K2083404 1.0 µg DNA
S100A10 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details